India business' average revenue per user is seen declining 3.5 percent QoQ to Rs 152.5 but volume growth may be 8.3 percent at 413 billion minutes and minutes of usage may increase 5.5 percent to 497.
Operating profit is expected to jump 55 percent to Rs 5,320 crore and margin may expand 530 basis points to 29.1 percent compared with year-ago quarter.
Key things to watch out for would be domestic volume growth that is expected to be 5-6 percent for the quarter, which would be upside risk for the stock.
Key things to watch out for would be asset quality movement. At the end of March 2017, total amount of loans under watchlist was Rs 11,232 crore (which accounts for 3 percent of total loan book).
Rise in commodity costs and high discounts may hit margin during the quarter but sequential margin is expected to improve as realisations improve and input price cooling off.
Operating profit may drop 9.4 percent to Rs 700 crore and margin may contract 50 basis points to 50.4 percent compared with same quarter last year.
Key factor to watch out for would be share buyback announcement. If the company announces 10 percent buyback then the company will have to shell out Rs 90.5 crore and Rs 226 crore for 25 percent buyback.
Operating profit may decline 3.2 percent to Rs 1,534.5 crore and margin may shrink 120 basis points to 43.8 percent compared with previous quarter.
Margin improvement is seen due to lower costs from sports business and other expenses while increase in other income may be due to sale of sports business.
Analysts feel if loan growth comes above 15 percent, domestic loan growth above 20 percent and net interest margin above 4 percent then that will be positive.
Wipro Q1 FY18 earnings beat expectations but guidance disappointed the street- the board has also approved a Rs 11,000 crore buyback. In an interview to CNBC-TV18, Sandip Agarwal of Edelweiss Financial Services shared his readings and outlook on the same.
Reliance Industries (RIL) has posted strong Q1 FY18 numbers on a consolidated basis and all eyes now are on the annual general meeting (AGM) this morning. In an interview to CNBC-TV18, Tarun Lakhotia of Kotak Securities spoke about the numbers as well as his expectations from the AGM.
Analysts believe that the margins have bottomed out and should start showing improvement YoY hereon, ending three years of contraction, from 26 percent in FY14 to 16 percent in FY17.
Operating profit is seen falling 24 percent to Rs 364 crore and margin may shrink 200 basis points to 9 percent on year-on-year basis, mainly due to negative operating leverage and higher raw material cost.
The refining margins would be around USD 11.2 a barrel compared to USD 11.5/barrel in the last quarter but the refining throughput would be better than the last quarter, said Nitin Tiwari of Antique Stock Broking.
Analysts expect the company to guide its dollar revenue growth in the range of 0-2 percent or 1-3 percent for July-September quarter.
Appreciation in rupee against US dollar may hurt net numbers, analysts feel.
Operating profit during the quarter is likely to drop 9 percent to Rs 1,075 crore and margin may be flat at 20 percent on year-on-year basis.
Low cost deposit flow may be strong for the bank, analysts feel.
Net Sales are expected to increase by 4 percent Q-o-Q (up 7.57 percent Y-o-Y) to Rs 369.5 crore, according to KR Choksey. Granules India to report net profit at 37.2 crore up 16.61% year-on-year.
Net Sales are expected to increase by 0.41 percent Q-o-Q (up 5.54 percent Y-o-Y) to Rs 266.7 crore, according to KR Choksey. Indoco Remedies to report net profit at 15 crore down 24.24% year-on-year.
Net Sales are expected to decrease by 6.86 percent Q-o-Q (down 6.29 percent Y-o-Y) to Rs 689.5 crore, according to KR Choksey. Alembic Pharma to report net profit at 86.3 crore down 16.70% year-on-year.
Net Sales are expected to decrease by 2.39 percent Q-o-Q (down 16.79 percent Y-o-Y) to Rs 6662 crore, according to KR Choksey. Sun Pharma to report net profit at 1713.2 crore down 24.69% year-on-year.
Net Sales are expected to decrease by 4.43 percent Q-o-Q (down 4.78 percent Y-o-Y) to Rs 3332.5 crore, according to KR Choksey. Cipla to report net profit at 199.6 crore down 46.52% year-on-year.
Net Sales are expected to increase by 0.12 percent Q-o-Q (down 90.34 percent Y-o-Y) to Rs 4167 crore, according to KR Choksey. Lupin to report net profit at 387.1 crore down 56.14% year-on-year.